ARROWHEAD PHARMACEUTICALS, INC. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC. for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2021 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 83.28 | 3,000 | 249,840 | 12,500 | 15.5 K to 12.5 K (-19.35 %) |
| Jan 15 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 81.82 | 3,814 | 312,061 | 126,250 | 130.1 K to 126.3 K (-2.93 %) | |
| Jan 15 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 80.97 | 6,186 | 500,880 | 130,064 | 136.3 K to 130.1 K (-4.54 %) | |
| Jan 12 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 81.00 | 1,441 | 116,721 | 444,005 | 445.4 K to 444 K (-0.32 %) |
| Jan 12 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 81.02 | 11,597 | 939,589 | 445,446 | 457 K to 445.4 K (-2.54 %) |
| Jan 08 2021 | ARWR | ARROWHEAD PHARMACE ... | Hassard James | Chief Commercial Of ... | Sell | S | 75.00 | 15,625 | 1,171,875 | 109,375 | 125 K to 109.4 K (-12.50 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 72.67 | 13,243 | 962,369 | 293,375 | 306.6 K to 293.4 K (-4.32 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 72.27 | 10,615 | 767,146 | 306,618 | 317.2 K to 306.6 K (-3.35 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 70.78 | 1,142 | 80,831 | 317,233 | 318.4 K to 317.2 K (-0.36 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 72.63 | 25,166 | 1,827,807 | 457,043 | 482.2 K to 457 K (-5.22 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 71.77 | 4,359 | 312,845 | 482,209 | 486.6 K to 482.2 K (-0.90 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 70.75 | 1,100 | 77,825 | 486,568 | 487.7 K to 486.6 K (-0.23 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 72.67 | 14,708 | 1,068,830 | 136,250 | 151 K to 136.3 K (-9.74 %) | |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 72.05 | 3,967 | 285,822 | 150,958 | 154.9 K to 151 K (-2.56 %) | |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 70.89 | 700 | 49,623 | 154,925 | 155.6 K to 154.9 K (-0.45 %) | |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 73.93 | 1,925 | 142,315 | 155,625 | 157.6 K to 155.6 K (-1.22 %) | |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 72.91 | 10,350 | 754,619 | 157,550 | 167.9 K to 157.6 K (-6.16 %) | |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 72.19 | 3,300 | 238,227 | 167,900 | 171.2 K to 167.9 K (-1.93 %) | |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 71.09 | 3,800 | 270,142 | 171,200 | 175 K to 171.2 K (-2.17 %) | |
| Jan 04 2021 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Grant | A | 0.00 | 800,000 | 0 | 3,344,022 | 2.5 M to 3.3 M (+31.45 %) |
| Jan 04 2021 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Gift | G | 0.00 | 599 | 0 | 2,544,022 | 2.5 M to 2.5 M (-0.02 %) |